Physician

Alex Sarmen Mirakian

According to 2025 Medicare claims, Alex Mirakian (NPI: 1598807778) practices radiation oncology, with the plurality of this provider's patient population coming from Jackson, FL. This provider's primary affiliated billing organization is LIMITLESS PARTNERS, LLC (NPI: 1538937677; TIN: 933867706) and primary practice location at 32446-1902. Mirakian is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Mirakian's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 94 traditional Medicare patients, billed 3,076 HCPCS/CPT codes, and received $556,575 in Medicare payments. The top billing code was G6015 (Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session). Part D data shows 59 prescription claims across 41 beneficiaries totaling $657 in drug costs, led by Tamsulosin Hcl (Tamsulosin Hcl). Open Payments data shows 8 records totaling $387. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $839,007 and ending at $556,575. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $22,286 to $657. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$862K$1.7M2015 Medicare payment: $839,007 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $536,372 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,390,152 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,306,261 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,724,403 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $90,837 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $878,436 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $470,443 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $328,853 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $556,575 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20154385,817$839,007
20164343,852$536,372
201770939,111$1,390,152
201866120,251$1,306,261
201962036,350$1,724,403
202074953$90,837
20211124,783$878,436
2022892,768$470,443
2023591,619$328,853
2024943,076$556,575

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$11K$23K2015 Drug cost: $22,286 (USD; Tot_Drug_Cst)2016 Drug cost: $22,963 (USD; Tot_Drug_Cst)2017 Drug cost: $8,755 (USD; Tot_Drug_Cst)2018 Drug cost: $5,015 (USD; Tot_Drug_Cst)2019 Drug cost: $5,869 (USD; Tot_Drug_Cst)2020 Drug cost: $417 (USD; Tot_Drug_Cst)2021 Drug cost: $5,486 (USD; Tot_Drug_Cst)2022 Drug cost: $3,485 (USD; Tot_Drug_Cst)2023 Drug cost: $1,084 (USD; Tot_Drug_Cst)2024 Drug cost: $657 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201574182$22,286
201654130$22,963
201796202$8,755
2018116225$5,015
2019121228$5,869
20201114$417
202186204$5,486
202260136$3,485
20232034$1,084
20244159$657

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
G6015Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session501,021$263
77427Radiation treatment management, 5 treatment sessions56236$147
77334Design and construction of complex radiation treatment device3451$93
77014Ct guidance for insertion of radiation therapy fields51904$90
77336Continuing radiation therapy consultation per week55223$67

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Tamsulosin HclTamsulosin Hcl13390$45

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.8$387AstraZeneca Pharmaceuticals LP
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Alex Sarmen Mirakian?

Tedicare shows public-source Medicare data for Alex Sarmen Mirakian (NPI 1598807778), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alex Sarmen Mirakian have ACO affiliation data?

Alex Sarmen Mirakian is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Alex Sarmen Mirakian?

Alex Sarmen Mirakian is linked to LIMITLESS PARTNERS, LLC (billing NPI 1538937677) in the available physician profile data.

Does Alex Sarmen Mirakian have Open Payments data?

Alex Sarmen Mirakian has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.